Back
AbbVie

AbbVie

ABBV

Loading Stocks

$162.25

$0.18 (-0.11%)

1D

1W

3M

1Y

5Y

ALL

Overview

AbbVie Inc. (AbbVie) is a research-based biopharmaceutical company. The Company is engaged in research and development, manufacturing, commercialization and sale of medicines and therapies. AbbVie offers its products in various therapeutic categories, including Immunology products, which include Humira, Skyrizi and Rinvoq; Oncology products consists of Imbruvica and Venclexta; Aesthetics products include Botox Cosmetic, Juvederm Collection and other aesthetics; Neuroscience products, such as Botox Therapeutic, Vraylar, Duopa and Duodopa, and Ubrelvy; Eye care products consists of Lumigan, Alphagan and Restasis ; Women's health products incudes Lo Loestrin, Orilissa and other women's health; and Other key products, which includes Mavyret, Creon, Lupron, Linzess and Synthroid. The Company's products are sold worldwide directly to wholesalers, distributors, government agencies, health care facilities and independent retailers from AbbVie-owned distribution centers and public warehouses.

Open

$163.36

Prior close

$162.73

Today's high

$163.99

Today's low

$161.89

52 Week high

$182.89

52 Week low

$130.96
News
AbbVie Tracking for New Highs in 2024
Newsfeed image icon
3 Reasons to Buy AbbVie Stock on the Dip
Newsfeed image icon
Here is What to Know Beyond Why AbbVie Inc. (ABBV) is a Trending Stock
Newsfeed image icon
View disclosures

Start Your Investing Journey At MoneyLion

Access fully managed portfolios to help you invest towards your future, without the heavy lifting.

Market Data

Charts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.